We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pathology

Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

A newly cleared digital pathology system expands interoperability and cloud support for primary diagnosis. More...
10 Aug 2026
image Credit: iStock

AI Pathology Tool Predicts Relapse Risk in Stage II Colorectal Cancer

An AI approach using routine pathology data predicts relapse risk in stage-two bowel cancer to focus monitoring and adjuvant care. More...
30 Jul 2026
Image: The AI analyzes digitized histology to identify tumor regions, distinguish cancerous from healthy cells, and quantify tumor cell density (Image Credit: Shutterstock)

AI Pathology Tool Stratifies Rectal Cancer to Guide Chemoradiotherapy

An AI approach measured tumor cell density in rectal cancer biopsies to predict benefit from irinotecan plus chemoradiotherapy. More...
28 Jul 2026
Image: Agilent’s PD-L1 IHC 22C3 pharmDx has received EU certification as a companion diagnostic to identify PD-L1–positive ovarian, fallopian tube, or primary peritoneal carcinoma patients eligible for KEYTRUDA (Photo courtesy of Agilent)

PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers

An EU‑certified companion diagnostic extends PD‑L1 testing to ovarian and related cancers to guide pembrolizumab eligibility. More...
27 Jul 2026
Image: Covering biopsies and excisions, the breast suite provides a fully IVDR-certified, end-to-end workflow across H&E, HER2, ER, PR, and Ki67-stained whole-slide images (Photo Courtesy of Ibex Medical Analytics)

AI Digital Pathology Platform Standardizes IHC Scoring in Breast Cancer

An AI system gains CE-IVDR for breast IHC, standardizing ER/PR/Ki67 and HER2 scoring to improve precision and workflow efficiency. More...
24 Jul 2026
Multiplex immunofluorescent (left) and H&E-stained (right) breast tumor samples illustrating high versus low Base Topology Scores. Higher topology scores reflect more organized tissue architecture, while lower scores indicate greater structural disorganization. By quantitatively measuring these structural differences, the researchers developed biomarkers that predicted patient outcomes more accurately than many traditional approaches. (Photo courtesy of Columbia University Irving Medical Center)

Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response

A topology-based approach quantifies tumor architecture to improve breast cancer prognosis and predict therapy response. More...
22 Jul 2026
Image: Atypical clustering of myeloid progenitor cells called myeloblasts (white arrows), defined by their co-expression of CD34 (magenta) and CD117 (green), in a bone marrow biopsy tissue from a patient with MDS. (Image Credit: Dr. Sanjay Patel)

AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity

An AI approach measures disease severity from routine bone marrow images, improving classification and ongoing monitoring of MDS. More...
20 Jul 2026
Visit expo >
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Multi-Chamber Washer-Disinfector
WD 390

In Other News



The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000 - 2026 Globetech Media.
All rights reserved.